الفهرس 
INTRODUCTIONOnly 14 pages are availabe for public view
 |  | from | 51 |  |  |
| | | from | 51 | | |
Abstract
There is no agreement on the best adnexal surgery to perform after an abdominal hysterectomy when it is sought to maintain hormone function with fewer long-term effects. In this prospective randomized study, the goal was to examine residual ovarian function after abdominal hysterectomy with preservation of either one or both ovaries. Seventy patients were divided into two groups at random and in consecutive order: those having bilateral salpingectomy with unilateral oophorectomy and abdominal hysterectomy, and those having bilateral salpingectomy with preservation of both ovaries. FSH and E 2 levels were measured before, one month, three months, and six months after the procedure to assess ovarian function.
The mean age of the patients in the current study was 45. The benign indications for abdominal hysterectomy were subserous fibroid, submucous fibroid, uterine adenomyosis and multiple interstitial fibroids.
In the present study, 34.3% of the patients who had undergone TAH with USO experienced climacteric symptoms such as vasomotor symptoms (loss of libido, diaphoresis), and vaginal dryness. The beginning of these symptoms appeared after 3 months in most of the patients with one conserved ovary. Whereas none of the patient with both conserved ovaries experienced such symptoms.
Women with unilateral oophorectomy at the time of hysterectomy had more risk of secondary ovarian lesions compared with those without oophorectomy at hysterectomy.